Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:TECK.B
TSX:TECK.BMetals and Mining

Teck Refocuses Copper Exploration On North America With Intrepid Metals Move

Teck Resources (TSX:TECK.B) plans to increase its stake in Intrepid Metals through a private placement that supports a multi year copper exploration program in North America. The company has also chosen to end its copper exploration alliance in Kazakhstan by terminating an option to acquire a major stake in local projects. Teck Resources is a diversified miner with significant exposure to copper, a metal closely tied to long term electrification and infrastructure themes. By committing more...
TSX:AGI
TSX:AGIMetals and Mining

Alamos Gold (TSX:AGI) Is Up 18.2% After Multi‑Year Production Guidance Update Has The Bull Case Changed?

In early February 2026, Alamos Gold released multi‑year guidance calling for higher gold production through 2028 and detailed how expansions at Island Gold, Young-Davidson, Mulatos and Lynn Lake are expected to support that profile, alongside an active mergers-and-acquisitions pipeline focused on value creation. Extensive exploration results across core assets, including high‑grade drilling success and low discovery costs at Island Gold and Lynn Lake, underscore management’s emphasis on...
NasdaqGS:KSPI
NasdaqGS:KSPIConsumer Finance

Kaspi.kz (NasdaqGS:KSPI) Valuation Check After Recent Shift In Share Price Performance

Kaspi.kz context and recent share performance Kaspi.kz (KSPI) has been drawing investor attention after recent trading, with the stock last closing at US$76.36 and showing mixed returns over the past month and past 3 months. See our latest analysis for Kaspi.kz. That recent 3.48% 1 day share price gain comes after a softer patch, with a 30 day share price return of 6.7% decline and a 1 year total shareholder return of 21.15% decline. This suggests momentum has cooled after earlier multi year...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Summit Therapeutics (SMMT) Is Up 6.5% After FDA Accepts Ivonescimab BLA With 2026 PDUFA Date

Summit Therapeutics Inc. previously announced that the FDA accepted for filing its Biologics License Application for ivonescimab plus chemotherapy in EGFR‑mutated, locally advanced or metastatic non-squamous NSCLC after tyrosine kinase inhibitor therapy, assigning a PDUFA action date of November 14, 2026. Beyond this U.S. filing, Summit and partner Akeso have broadened ivonescimab’s late-stage program across multiple Phase III trials and tumor types, underscoring a concerted push to position...
NYSE:XPEV
NYSE:XPEVAuto

XPeng Hong Kong Charging Deal With Antom Highlights Global Services Ambition

XPeng has launched smart charging payment services in Hong Kong through a global partnership with Antom. The rollout introduces a unified system that supports multiple local payment methods for EV charging. The service is designed to simplify cross border charging payments for XPeng drivers and other EV users. XPeng (NYSE:XPEV), trading at around $17.54, is adding this smart charging payment launch to a period of mixed share performance, with the stock up 6.4% over the past week but lower...
NYSE:MTD
NYSE:MTDLife Sciences

Mettler Toledo Q4 Service Milestone Highlights Growth And Valuation Tension

Mettler-Toledo International (NYSE:MTD) reported strong Q4 results, with broad-based growth across regions and product lines. The company reached US$1b in annual service revenue for the first time, marking a key milestone in its service business. Management highlighted continued progress in automation and digitalization initiatives, alongside expansion in emerging markets and high-growth segments. Results came despite ongoing headwinds from tariffs and currency movements. Mettler-Toledo...
TSX:SAP
TSX:SAPFood

Profit Rebound and Efficiency Push Might Change The Case For Investing In Saputo (TSX:SAP)

Saputo Inc. recently reported third-quarter fiscal 2025 results showing sales of C$4,888 million, a return to net income of C$220 million from a sizeable loss a year earlier, while also affirming a C$0.20 per-share dividend payable in March 2026. The company coupled this profitability rebound with ongoing capital investment and manufacturing consolidation, including a C$180 million Ripon facility upgrade and completed share repurchases totaling 19,882,237 shares for C$586.36 million under a...
BME:GRF
BME:GRFBiotechs

Is Grifols (BME:GRF) Share Price Reflecting Recent Balance Sheet Concerns?

If you are wondering whether Grifols at €11.06 is offering fair value or a potential discount, you are in the right place for a clear, valuation focused look at the stock. The share price return sits at 1% over the last week, with a 2.9% decline over the past month and a 32% gain over the last year, which can change how investors think about both upside potential and risk. Recent headlines around Grifols have kept the company on many investors' radar, including ongoing discussion of its...
TSX:BCE
TSX:BCETelecom

Assessing BCE (TSX:BCE) Valuation After 2025 Results And Cautious 2026 Guidance

Why BCE (TSX:BCE) is back in focus after its latest results BCE (TSX:BCE) is drawing fresh attention after reporting its fourth quarter and full year 2025 results, issuing 2026 guidance, and affirming its quarterly dividend on the same day. The company reported Q4 2025 revenue of CA$6,404 million compared with CA$6,422 million a year earlier, with net income of CA$630 million compared with CA$504 million and basic EPS from continuing operations of CA$0.64 compared with CA$0.51. For 2025 as a...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen Refocuses On High-Need Neurology As New Drugs Reach Inflection Point

Biogen (NasdaqGS:BIIB) reports strong commercial performance for Alzheimer’s treatment Leqembi, reflected in collaboration revenues and in market sales. The US FDA grants Breakthrough Therapy Designation to litifilimab for cutaneous lupus erythematosus, marking a key step in Biogen’s immunology efforts. Biogen announces promising clinical results for a high dose SPINRAZA regimen for spinal muscular atrophy, with regulatory review ongoing in the US and approvals already in the EU and...
SGX:D05
SGX:D05Banks

Assessing DBS Group Holdings (SGX:D05) After Strong 1‑Year Rally And Regulatory Focus

If you are wondering whether DBS Group Holdings is offering fair value at today’s price, you are not alone. This article will walk through what the current market price might be implying. With the share price at S$58.19 and returns of 3.2% year to date and 36.0% over the past year, DBS has been on many investors’ watchlists. This is despite a 1.2% decline over the last 7 days and a more modest 1.0% return over the past month. Recent news around DBS has largely focused on its position as a...
TASE:ORL
TASE:ORLOil and Gas

Middle Eastern Penny Stocks To Watch In February 2026

As tensions ease following positive US-Iran talks, most Gulf stocks have risen, supported by upbeat corporate earnings. This optimistic market environment highlights the potential for smaller or newer companies to gain traction and deliver value. Although 'penny stock' is an older term, it still signifies opportunities in these emerging firms when they are backed by strong financials and growth potential.
TASE:ATRY
TASE:ATRYCapital Markets

Middle Eastern Dividend Stocks To Consider In February 2026

In recent weeks, Middle Eastern markets have experienced a notable upswing, driven by eased geopolitical tensions and strong corporate earnings. As investors navigate this optimistic landscape, dividend stocks offer a compelling opportunity for those seeking steady income amidst the region's dynamic market conditions.
NYSE:MGM
NYSE:MGMHospitality

MGM Resorts International (MGM) Is Up 13.6% After Record Macau Profitability And Major Buybacks

MGM Resorts International recently reported fourth-quarter 2025 results showing higher sales of US$3,433.3 million and revenue of US$4,605.27 million, alongside completing two share repurchase programs totaling US$2,389.19 million and recording a US$22.79 million goodwill impairment. Management highlighted record profitability in Macau, a sharp improvement at BetMGM, and the easing of renovation-related disruption in Las Vegas as key operational themes. With these updates and management’s...
NYSE:KNTK
NYSE:KNTKOil and Gas

Is Kinetik Holdings (KNTK) Pricing Look Attractive After Recent Share Price Rebound

If you are looking at Kinetik Holdings and wondering whether the recent price is fair, rich, or leaves some room on the table, you are in the right place for a clear look at value. The stock closed at US$42.25, with returns of 5.3% over the last 7 days, 15.1% over the last 30 days, 15.9% year to date, and a 28.4% decline over the past year, while the 3 year return sits at 80.7%. These moves are sitting against a backdrop of ongoing interest in US energy infrastructure and midstream names,...
NasdaqGS:APP
NasdaqGS:APPSoftware

Is It Time To Reconsider AppLovin (APP) After Sharp Share Price Pullback and DCF Results

If you are wondering whether AppLovin is still worth a spot on your watchlist at current prices, this article focuses squarely on what the numbers say about its value. The share price closed at US$460.38, with a 7 day return of 4.7% decline, a 30 day return of 28.9% decline and a year to date return of 25.5% decline, while the 1 year return is 19.8% and the 3 year return is a very large gain. Recent news around AppLovin has focused on its role in mobile app marketing and software, which has...
NYSE:APO
NYSE:APODiversified Financial

Apollo Schroders Partnership Targets Hybrid Products And Long Term Growth

Apollo Global Management (NYSE:APO) has entered a partnership with Schroders to create hybrid investment products for wealth and retirement clients. The collaboration brings together public and private market expertise to address demand for more diversified portfolios. Initial products are expected to launch in the UK and US, with the partners targeting multi billion dollar flows per year. Apollo Global Management, trading at $133.95, is expanding further into the wealth and retirement...
SWX:PGHN
SWX:PGHNCapital Markets

Assessing Partners Group Holding (SWX:PGHN) Valuation After New Private Markets SMA Launch

Why this new SMA launch matters for Partners Group Holding (SWX:PGHN) BlackRock and Partners Group Holding (SWX:PGHN) have introduced a multi alternatives separately managed account solution that packages private equity, private credit, and real assets access for financial advisors in a single, streamlined offering. See our latest analysis for Partners Group Holding. The new SMA launch comes after a weaker recent stretch for the shares, with a 7 day share price return showing a 6.49% decline...